Literature DB >> 6473070

Perfluorochemicals as a treatment of decompression sickness in rats.

J Lutz, G Herrmann.   

Abstract

Perfluorodecalin and perfluorotripropylamine which have N2 solubility coefficients of 28.4 and 35.7 ml/dl, respectively, were used for treatment of decompression sickness in this study. Rats with chronically implanted venous catheters were held for 30 min at 800 kPa (7 bar, 8 ATA) by introducing compressed air into a chamber in which they were kept; a relatively short period of decompression followed (200 kPa/min). Immediately thereafter injections of the perfluorochemicals (PFCs) in a dose of 10 g/kg were given, controls received saline in the same volume or remained without treatment. An observation period of 2 h followed; after this time the incidence of death amongst the experimental animals (as compared with controls tested by the chi 2-test) showed that PFC treatment increased the likelihood of survival. Probit-log time relationship for the incidence of death also revealed a significant decrease in lethality in treated rats 30 min after the end of decompression. The mean lethal times Lt50 differed significantly, too. A still greater effect might be expected if the PFC emulsion were deprived of its normal nitrogen content by oxygenation before administration. Under the conditions of the present experiments PFCs produced an improvement in N2 exhalation at least in terms of the survival rate after compression followed by a very short decompression time.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6473070     DOI: 10.1007/bf00583878

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  9 in total

1.  Relationship between saturation exposure pressure and subsequent decompression sickness in mice.

Authors:  T E Berghage; F W Armstrong; K J Conda
Journal:  Aviat Space Environ Med       Date:  1975-03

2.  Cross-adaptive effects of cold, hypoxia, or physical training on decompression sickness in mice.

Authors:  B A Rattner; S P Gruenau; P D Altland
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-08

3.  Fate of perfluorochemicals in animals after intravenous injection or hemodilution with their emulsions.

Authors:  K Yokoyama; K Yamanouchi; H Ohyanagi; T Mitsuno
Journal:  Chem Pharm Bull (Tokyo)       Date:  1978-03       Impact factor: 1.645

4.  Gas phase separation following decompression in asymptomatic rats: visual and ultrasound monitoring.

Authors:  M R Powell
Journal:  Aerosp Med       Date:  1972-11

5.  Intravascular changes associated with hyperbaric decompression: Theoretical considerations using ultrasound.

Authors:  R Y Nishi; S D Livingstone
Journal:  Aerosp Med       Date:  1973-02

6.  Use of heparin for the therapeutic-prophylactic treatment of decompression sickness.

Authors:  E Reeves; R D Workman
Journal:  Aerosp Med       Date:  1971-01

7.  Variation in toxicity of Escherichia coli endotoxin after treatment with perfluorated blood substitutes in mice.

Authors:  J Lutz; U Barthel; P Metzenauer
Journal:  Circ Shock       Date:  1982

8.  On comparing regression lines with unequal slopes.

Authors:  G O Zerbe; P G Archer; N Banchero; A J Lechner
Journal:  Am J Physiol       Date:  1982-03

9.  Effects of potential blood substitutes (perfluorochemicals) on rat liver and spleen.

Authors:  J Lutz; P Metzenauer
Journal:  Pflugers Arch       Date:  1980-09       Impact factor: 3.657

  9 in total
  4 in total

1.  Treatment of micro air bubbles in rat adipose tissue at 25 kPa altitude exposures with perfluorocarbon emulsions and nitric oxide.

Authors:  Thomas Randsøe; O Hyldegaard
Journal:  Eur J Appl Physiol       Date:  2013-10-25       Impact factor: 3.078

Review 2.  Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids.

Authors:  Pedro Cabrales; Marcos Intaglietta
Journal:  ASAIO J       Date:  2013 Jul-Aug       Impact factor: 2.872

Review 3.  Perfluorocarbons for the treatment of decompression illness: how to bridge the gap between theory and practice.

Authors:  Dirk Mayer; Katja Bettina Ferenz
Journal:  Eur J Appl Physiol       Date:  2019-11-04       Impact factor: 3.078

Review 4.  Perfluorocarbon-based oxygen carriers: from physics to physiology.

Authors:  Johannes Jägers; Anna Wrobeln; Katja B Ferenz
Journal:  Pflugers Arch       Date:  2020-11-03       Impact factor: 3.657

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.